Clinical Trial Update: A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year

View source ↗

Summary

This multicenter trial evaluated converting liver transplant recipients from Prograf to Advagraf during the first year after transplantation. The study is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma S.A.S. | Conditions: Liver Transplantation | Status: COMPLETED